Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Department of Respiratory Therapy, Sijhih Cathay General Hospital, New Taipei, Taiwan.
Respir Res. 2024 Jan 4;25(1):9. doi: 10.1186/s12931-023-02648-3.
Patients with influenza-related acute respiratory distress syndrome (ARDS) are critically ill and require mechanical ventilation (MV) support. Prolonged mechanical ventilation (PMV) is often seen in these cases and the optimal management strategy is not established. This study aimed to investigate risk factors for PMV and factors related to weaning failure in these patients.
This retrospective cohort study was conducted by eight medical centers in Taiwan. All patients in the intensive care unit with virology-proven influenza-related ARDS requiring invasive MV from January 1 to March 31, 2016, were included. Demographic data, critical illness data and clinical outcomes were collected and analyzed. PMV is defined as mechanical ventilation use for more than 21 days.
There were 263 patients with influenza-related ARDS requiring invasive MV enrolled during the study period. Seventy-eight patients had PMV. The final weaning rate was 68.8% during 60 days of observation. The mortality rate in PMV group was 39.7%. Risk factors for PMV were body mass index (BMI) > 25 (kg/m) [odds ratio (OR) 2.087; 95% confidence interval (CI) 1.006-4.329], extracorporeal membrane oxygenation (ECMO) use (OR 6.181; 95% CI 2.338-16.336), combined bacterial pneumonia (OR 4.115; 95% CI 2.002-8.456) and neuromuscular blockade use over 48 h (OR 2.8; 95% CI 1.334-5.879). In addition, risk factors for weaning failure in PMV patients were ECMO (OR 5.05; 95% CI 1.75-14.58) use and bacteremia (OR 3.91; 95% CI 1.20-12.69).
Patients with influenza-related ARDS and PMV have a high mortality rate. Risk factors for PMV include BMI > 25, ECMO use, combined bacterial pneumonia and neuromuscular blockade use over 48 h. In addition, ECMO use and bacteremia predict unsuccessful weaning in PMV patients.
流感相关急性呼吸窘迫综合征(ARDS)患者病情危急,需要机械通气(MV)支持。此类患者常需要长时间机械通气(PMV),但最佳管理策略尚未确定。本研究旨在探讨此类患者发生 PMV 的危险因素和撤机失败的相关因素。
本回顾性队列研究由台湾的 8 家医疗中心进行。纳入 2016 年 1 月 1 日至 3 月 31 日期间因病毒确诊的流感相关 ARDS 而需要有创 MV 的重症监护病房患者。收集并分析患者的人口统计学数据、危重症数据和临床结局。PMV 定义为机械通气使用时间超过 21 天。
研究期间共纳入 263 例因流感相关 ARDS 而需要有创 MV 的患者,其中 78 例发生 PMV。在 60 天的观察期内,最终撤机率为 68.8%。PMV 组的死亡率为 39.7%。PMV 的危险因素包括 BMI(体重指数)>25(kg/m)[比值比(OR)2.087;95%置信区间(CI)1.006-4.329]、体外膜肺氧合(ECMO)[OR 6.181;95% CI 2.338-16.336]、合并细菌性肺炎[OR 4.115;95% CI 2.002-8.456]和 48 小时以上使用神经肌肉阻滞剂[OR 2.8;95% CI 1.334-5.879]。此外,PMV 患者撤机失败的危险因素包括 ECMO[OR 5.05;95% CI 1.75-14.58]和菌血症[OR 3.91;95% CI 1.20-12.69]的使用。
流感相关 ARDS 合并 PMV 的患者死亡率较高。PMV 的危险因素包括 BMI>25、ECMO 应用、合并细菌性肺炎和神经肌肉阻滞剂使用时间超过 48 小时。此外,ECMO 应用和菌血症预示着 PMV 患者撤机失败。